<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/ikt" ></link>
<id>urn:uuid:0486d2b6-d7cd-a8f4-5fa3-4564d4d9e577</id>
<updated>2026-08-15T16:20:14-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>IKT: RA CAPITAL MANAGEMENT L P (BO) Disposed (JS) 18.0mm Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 7/29</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6446905" ></link>
<id>urn:uuid:0ecf1d9a-1ce8-27f4-52ef-7d2aaa24b3f6</id>
<updated>2026-07-31T16:32:20-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: BERMAN DENNIS N (DIR) Exercised 21,854 Options (OB) of INHIBIKASE THERAPEUTICS INC for $1.26 on 7/30, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6446819" ></link>
<id>urn:uuid:a7d9b318-8281-f0e9-b354-6e8b9dd79842</id>
<updated>2026-07-31T16:05:14-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: RA CAPITAL MANAGEMENT L P (BO) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Indirect Holdings of 25mm</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6443030" ></link>
<id>urn:uuid:ac1fa4a9-fda6-323d-57b3-0369b15060a1</id>
<updated>2026-07-17T17:54:40-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: AURENTZ VINCENT (DIR) Disposed (JS) 255,299 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339719" ></link>
<id>urn:uuid:5270e5c4-5d48-ee39-d341-e55d4bbec782</id>
<updated>2026-02-24T20:54:26-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: CABELL CHRISTOPHER (PR) Disposed (JS) 338,282 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339724" ></link>
<id>urn:uuid:44c71558-6a34-2121-dffc-abe4886c2e49</id>
<updated>2026-02-24T20:53:37-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: MUNSHI AMIT (DIR) Disposed (JS) 19,089 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6339713" ></link>
<id>urn:uuid:26737d9b-497b-ae91-b44b-ec44f41dd060</id>
<updated>2026-02-24T20:48:55-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: SANDS CAPITAL LIFE SCIENCES PULSE FUND II L P (BO) Bought (JB*) 2.1mm Shares of INHIBIKASE THERAPEUTICS INC for $1.45 on 11/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6281095" ></link>
<id>urn:uuid:064ac8b6-5b88-41f5-9a61-aed30e16ab60</id>
<updated>2025-11-24T15:47:02-05:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: CABELL CHRISTOPHER (PR) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 1.0mm</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247609" ></link>
<id>urn:uuid:cc9b7587-c8be-eec2-5053-eb036f47d5c8</id>
<updated>2025-08-28T19:52:09-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: AURENTZ VINCENT (DIR) Filed a Form 3, Becoming a Registered Insider at INHIBIKASE THERAPEUTICS INC With Initial Direct Holdings of 765,895</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247608" ></link>
<id>urn:uuid:5e4784ea-6af2-db04-d602-c0d0d626416c</id>
<updated>2025-08-28T19:50:18-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
<entry>
<title>IKT: MUNSHI AMIT (DIR) Acquired (JB) 57,265 Shares of INHIBIKASE THERAPEUTICS INC for $0.00 on 2/21</title>
<link href="http://www.insiderinsights.com/company/ikt/inhibikase-therapeutics-inc/id-6247610" ></link>
<id>urn:uuid:da10ef1c-c9f3-d008-72c3-6989eab25db0</id>
<updated>2025-08-28T19:48:20-04:00</updated>
<summary type="html" ><![CDATA[INHIBIKASE THERAPEUTICS INC (IKT). Recent Price: $2.41. Mkt Cap:336.3mm. 10D Vol: 560,480]]></summary>
</entry>
</feed>